These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results Terminated 2007-005166-12 A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients with Mild to Moderate Active Ulcerative Colitis with or without Mesalamine bad-data
Completed, report not yet due 2020-000158-88 A Global, Multi Center, Randomized, Placebo-Controlled Phase 3 Trial to Compare the Efficacy and Safety of Fruquintinib Plus Best Supportive Care to Placebo Plus Best Supportive Care in Patients with ... 2024-04-24 not-yet-due
Exempt 2020-004163-12 An Open-Label Phase Ib/II Study of Surufatinib in Combination with Tislelizumab in Subjects With Advanced Solid Tumors not-yet-due
Listed as ongoing, but also has a completion date 2020-006118-19 An Open-Label Phase 2 Study of Surufatinib in Patients with Neuroendocrine Tumours in Europe 2024-09-06 bad-data